InvestorsHub Logo
icon url

rayovacAAA

12/01/20 3:57 PM

#285771 RE: XenaLives #285765

RATHER ODD AN EXPERT LIKE HAMPEL LEFT THE AVXL TEAM AND WENT TO EISAI!!!!!!!!!!!!


Rather odd that experts like Hampel, Kaufmann and Aarsland have been taken in by this so-called "fraud".





https://www.fiercebiotech.com/biotech/eisai-installs-new-alzheimer-s-clinical-trial-leadership-team


Eisai unveiled the transfer of Irizarry to the new role alongside news of the appointment of Harald Hampel as VP, global medical affairs, Alzheimer's. The appointment puts Hampel in charge of coming up with Eisai’s global medical strategies in Alzheimer's and dementia. And he'll oversee phase 3b and 4 clinical trials of Alzheimer’s drugs, if one makes it that far.




GOOD LUCK AND GOD BLESS!!!!